TrumpRx has generated enormous interest, with related searches reaching over 70,000 in trend score. For millions of Americans who can't afford GLP-1 meds, the question is simple: will this make them cheaper?
What Is TrumpRx?
It's a prescription drug pricing initiative that aims to lower costs through:
- Direct price negotiations with drug makers
- Importation programs from countries with lower prices
- Transparency requirements – forcing companies to justify price hikes
- Medicare negotiation expansion
How It Could Affect GLP-1 Meds
GLP-1 meds cost $10,000-$18,000 per year. Any pricing reform could make a big difference.
Potential Good
- Lower list prices through negotiations
- More competition
- More insurance plans covering GLP-1
- Possible Medicare access for obesity treatment
What's Uncertain
- Timeline – Policy changes take time
- Legal challenges – Drug companies fight pricing rules in court
- Scope – It's unclear if weight loss GLP-1 meds would be included
- Politics – Policies can change with administrations
Current GLP-1 Pricing (Without Insurance)
| Medication | Monthly Cost | Annual Cost |
|---|---|---|
| Ozempic | $900-$1,200 | $10,800-$14,400 |
| Wegovy | $1,100-$1,400 | $13,200-$16,800 |
| Mounjaro | $1,000-$1,300 | $12,000-$15,600 |
| Zepbound | $1,000-$1,400 | $12,000-$16,800 |
| Saxenda | $1,200-$1,500 | $14,400-$18,000 |
These prices are out of reach for most people without insurance or savings programs.
What You Can Do Right Now
1. Manufacturer Savings Cards
- Wegovy savings card – Eligible patients may pay as little as $0/month
- Mounjaro savings card – Up to $150 off per month
- Zepbound savings card – Similar savings for weight management
See our guides on Mounjaro savings and Zepbound savings.
2. Insurance Coverage
Coverage varies widely. See our insurance guide.
3. Telehealth
Some platforms offer competitive bundled pricing. See our telehealth guide.
4. Self-Pay
Some pharmacies offer lower-than-list pricing. See our self-pay guide.
Wegovy vs Zepbound: Which Is More Affected?
Wegovy
- Most prescribed GLP-1 for weight loss
- Made by Novo Nordisk (Danish company)
- Oral version now available
- Patents extend into the 2030s
Zepbound
- Newer, potentially more effective (dual GLP-1/GIP action)
- Made by Eli Lilly (American company)
- Higher demand than supply
- Similar patent protection
Neither is likely to get dramatically cheaper until generics arrive (late 2030s at earliest).
The Bigger Picture
Over 100 million Americans have obesity or prediabetes. Fewer than 5 million use GLP-1 meds. The gap is tens of millions of people who could benefit but can't afford it.
FAQ
What is TrumpRx and how does it affect GLP-1 prices?
It's a drug pricing initiative aimed at lowering costs. Its specific impact on GLP-1 meds is still uncertain.
Will Wegovy get cheaper?
Too early to tell. Savings cards and insurance remain the best ways to reduce costs today.
What's the cheapest way to get Wegovy or Zepbound?
Manufacturer savings cards offer the biggest discounts. Some insured patients pay $0/month.
Are there generic versions?
No. Both are under patent protection into the 2030s.
The Bottom Line
TrumpRx has put GLP-1 pricing in the spotlight, which is good for patients. But real price changes will take time. In the meantime, explore savings cards, insurance options, and telehealth platforms.
This article is for information only and is not medical, legal, or financial advice.
